The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
The FDA approved Vertex Pharmaceuticals' Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...
Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing ...
WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction ...
The Zacks Medical - Biomedical and Genetics industry, to which Vertex belongs, has lost 7.2% over this period. Now the key question is: Where could the stock be headed in the near term?